PRESS RELEASE published on 05/23/2024 at 14:00, 3 months 27 days ago Bausch Health, Canada Inc. Announces Additional Public Drug Plan Listings for PrUCERIS(R) (Budesonide) Aerosol Foam To Treat Mild to Moderate Distal Ulcerative Colitis in Adults Bausch Health Canada expands UCERIS availability in Canadian public drug plans for ulcerative colitis treatment. UCERIS foam offers better tolerability and application compared to enema Ulcerative Colitis UCERIS Public Drug Plans Bausch Health Canada Gastrointestinal Franchise
BRIEF published on 05/17/2024 at 14:05, 4 months 2 days ago Salix Pharmaceuticals dévoilera les résultats de phase 2 de l'Amiselimod lors de la Semaine des maladies digestives 2024 Rectocolite Hémorragique Essai Clinique Salix Pharmaceutique Amiselimod Semaine Des Maladies Digestives
BRIEF published on 05/17/2024 at 14:05, 4 months 2 days ago Salix Pharmaceuticals to Unveil Amiselimod Phase 2 Results at Digestive Disease Week 2024 Salix Pharmaceuticals Ulcerative Colitis Clinical Trial Digestive Disease Week Amiselimod
PRESS RELEASE published on 05/17/2024 at 14:00, 4 months 2 days ago Salix to Present Late-Breaking Data from Phase 2 Trial of Amiselimod in Active Ulcerative Colitis at Digestive Disease Week 2024 Bausch Health & Salix Pharmaceuticals to present Phase 2 trial data on Amiselimod for ulcerative colitis treatment at DDW 2024. Positive results announced in 2023 Salix Pharmaceuticals Ulcerative Colitis Bausch Health DDW 2024 Amiselimod
BRIEF published on 05/15/2024 at 14:05, 4 months 4 days ago Bausch Health Announces 2024 Annual Meeting of Shareholder Results Corporate Governance Bausch Health Shareholder Meeting Executive Compensation Omnibus Incentive Plan
BRIEF published on 05/15/2024 at 14:05, 4 months 4 days ago Bausch Health annonce les résultats de l’assemblée annuelle des actionnaires 2024 Assemblée Générale Gouvernance D'Entreprise Bausch Santé Rémunération Des Dirigeants Plan Incitatif Omnibus
PRESS RELEASE published on 05/15/2024 at 14:00, 4 months 4 days ago Bausch Health Announces 2024 Annual Meeting of Shareholder Results Bausch Health Companies Inc. announces results of 2024 annual meeting of shareholders, including election of directors and approval of executive compensation Shareholders Bausch Health Companies Inc. Annual Meeting Directors Executive Compensation
BRIEF published on 05/14/2024 at 22:26, 4 months 4 days ago Bausch Health Announces Updates on Norwich XIFAXAN Litigation and New FDA Submission XIFAXAN Bausch Health Patent Litigation FDA Submission Norwich Pharmaceuticals
BRIEF published on 05/14/2024 at 22:26, 4 months 4 days ago Bausch Health annonce des mises à jour sur le litige Norwich XIFAXAN et une nouvelle soumission à la FDA XIFAXAN Bausch Santé Contentieux Des Brevets Norwich Pharmaceutique Soumission À La FDA
PRESS RELEASE published on 05/14/2024 at 22:21, 4 months 4 days ago Bausch Health Announces Updates Related to Norwich XIFAXAN Matters Bausch Health and Salix Pharmaceuticals provide updates on litigation with Norwich Pharmaceuticals and potential generic version of XIFAXAN. Bausch Health to enforce intellectual property rights. Details on FDA approval process and patent infringement lawsuit Salix Pharmaceuticals XIFAXAN Bausch Health Norwich Pharmaceuticals Intellectual Property Rights
Published on 09/19/2024 at 17:30, 1 hour 4 minutes ago Airborne Geophysical Survey Completed at Pine Channel Gold Project, Saskatchewan
Published on 09/19/2024 at 17:00, 1 hour 34 minutes ago Cypress Creek Consulting Advises Charter Communications on Inaugural Securitization Financing Facility
Published on 09/19/2024 at 15:45, 2 hours 49 minutes ago eLearners Make eLearning a Daily or Weekly Habit, Voices' eLearning Report Finds
Published on 09/19/2024 at 15:20, 3 hours 14 minutes ago Taurus secures "Best Digital Assets Solution" at 2024 Global BankTech Awards
Published on 09/19/2024 at 15:01, 3 hours 33 minutes ago ful. CashPay: Revolutionizing Healthcare Access for Employers With Uninsured Team Members
Published on 09/19/2024 at 17:52, 41 minutes ago PILOT 28 : FIGEAC AÉRO remporte 3 nouveaux contrats sur l'A320 pour 65 millions d'euros
Published on 09/19/2024 at 17:52, 41 minutes ago PILOT 28: FIGEAC AÉRO secures 3 new wins on the A320 airframe for 65 million euros
Published on 09/19/2024 at 17:52, 42 minutes ago EQS-Adhoc: SMT Scharf AG: New CEO joins the Managing Board
Published on 09/19/2024 at 17:45, 49 minutes ago AFG Holding SA acquiert une participation majoritaire dans le groupe allemand Access Holding et prend ainsi le contrôle de
Published on 09/19/2024 at 17:45, 49 minutes ago Gimv draagt helft van participatie in Infravest over aan WorxInvest (communicatie in toepassing van artikel 7:97 WVV)
Published on 09/19/2024 at 17:45, 49 minutes ago Gimv sells half of participation in Infravest to WorxInvest (communication pursuant to article 7:97 BCAC)
Published on 09/19/2024 at 17:45, 49 minutes ago Gimv sells half of participation in Infravest to WorxInvest (communication pursuant to article 7:97 BCAC)